HTR3A
Basic information
Region (hg38): 11:113975075-113990313
Previous symbols: [ "HTR3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTR3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 34 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 35 | 6 | 6 |
Variants in HTR3A
This is a list of pathogenic ClinVar variants found in the HTR3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-113975319-G-T | Benign (Aug 20, 2018) | |||
11-113977783-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
11-113977835-C-A | not specified | Uncertain significance (Aug 15, 2023) | ||
11-113977839-A-G | not specified | Uncertain significance (Jun 22, 2021) | ||
11-113977870-G-T | not specified | Uncertain significance (Aug 10, 2021) | ||
11-113977879-C-T | not specified | Uncertain significance (May 23, 2023) | ||
11-113977919-C-A | not specified | Uncertain significance (Jul 17, 2023) | ||
11-113979273-G-C | not specified | Uncertain significance (Jan 04, 2022) | ||
11-113981321-C-T | Benign (Jun 11, 2018) | |||
11-113981322-G-A | Likely benign (Jun 18, 2018) | |||
11-113983121-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
11-113983128-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
11-113983131-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
11-113983153-C-T | Likely benign (Oct 01, 2022) | |||
11-113983154-G-T | not specified | Uncertain significance (May 30, 2023) | ||
11-113983164-G-A | not specified | Likely benign (Apr 05, 2023) | ||
11-113983169-C-A | not specified | Uncertain significance (Oct 17, 2023) | ||
11-113983175-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
11-113983215-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
11-113983263-T-G | not specified | Uncertain significance (Oct 05, 2022) | ||
11-113986038-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
11-113986116-C-T | not specified | Uncertain significance (May 04, 2023) | ||
11-113986125-C-T | Likely benign (Aug 22, 2018) | |||
11-113986150-AC-A | Uncertain significance (Jan 11, 2024) | |||
11-113986159-C-G | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HTR3A | protein_coding | protein_coding | ENST00000355556 | 8 | 15433 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.75e-10 | 0.385 | 125497 | 2 | 249 | 125748 | 0.000999 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.17 | 350 | 294 | 1.19 | 0.0000187 | 3334 |
Missense in Polyphen | 120 | 113.43 | 1.0579 | 1335 | ||
Synonymous | -0.533 | 136 | 128 | 1.06 | 0.00000860 | 1075 |
Loss of Function | 1.03 | 18 | 23.4 | 0.769 | 0.00000129 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0122 | 0.0122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000924 | 0.000925 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.000924 | 0.000925 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor is a ligand-gated ion channel, which when activated causes fast, depolarizing responses in neurons. It is a cation-specific, but otherwise relatively nonselective, ion channel. {ECO:0000269|PubMed:12867984, ECO:0000269|PubMed:9950429}.;
- Pathway
- Serotonergic synapse - Homo sapiens (human);Taste transduction - Homo sapiens (human);Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics;Selective serotonin reuptake inhibitors lead to several adverse outcomes;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Neuronal System;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses
(Consensus)
Recessive Scores
- pRec
- 0.241
Intolerance Scores
- loftool
- 0.202
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.86
Haploinsufficiency Scores
- pHI
- 0.271
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.264
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Htr3a
- Phenotype
- homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- signal transduction;serotonin receptor signaling pathway;chemical synaptic transmission;positive regulation of ion transmembrane transporter activity;ion transmembrane transport;response to cocaine;regulation of membrane potential;response to ethanol;nervous system process;cellular response to growth factor stimulus
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;cell junction;axon;cleavage furrow;neuron projection;neuronal cell body;synapse;glutamatergic synapse;integral component of postsynaptic membrane;integral component of presynaptic membrane;serotonin-activated cation-selective channel complex
- Molecular function
- transmembrane signaling receptor activity;extracellular ligand-gated ion channel activity;protein binding;serotonin-gated cation-selective channel activity;serotonin binding